ArticleJournal of ovarian research2019

Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer.

Samantha Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.